Alembic Pharmaceuticals completes ANVISA GMP audit for API-II Facility in Panelav

11 Dec 2024 Evaluate

Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-II Facilty at Panelav for its 8 APIs. The inspection was conducted from September 16, 2024 to September 20, 2024.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company.


Alembic Pharma Share Price

1056.00 20.25 (1.96%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.